104 related articles for article (PubMed ID: 9101031)
1. Anthropometrical measurements and androgen levels in males, females, and hormonally untreated female-to-male transsexuals.
Bosinski HA; Schröder I; Peter M; Arndt R; Wille R; Sippell WG
Arch Sex Behav; 1997 Apr; 26(2):143-57. PubMed ID: 9101031
[TBL] [Abstract][Full Text] [Related]
2. A higher rate of hyperandrogenic disorders in female-to-male transsexuals.
Bosinski HA; Peter M; Bonatz G; Arndt R; Heidenreich M; Sippell WG; Wille R
Psychoneuroendocrinology; 1997 Jul; 22(5):361-80. PubMed ID: 9279941
[TBL] [Abstract][Full Text] [Related]
3. Masculinity, femininity, and transsexualism.
Herman-Jeglińska A; Grabowska A; Dulko S
Arch Sex Behav; 2002 Dec; 31(6):527-34. PubMed ID: 12462479
[TBL] [Abstract][Full Text] [Related]
4. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
Vermeulen A; Kaufman JM; Giagulli VA
J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841
[TBL] [Abstract][Full Text] [Related]
5. Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status.
Gravholt CH; Svenstrup B; Bennett P; Sandahl Christiansen J
Clin Endocrinol (Oxf); 1999 Jun; 50(6):791-800. PubMed ID: 10468952
[TBL] [Abstract][Full Text] [Related]
6. Typical female 2nd-4th finger length (2D:4D) ratios in male-to-female transsexuals-possible implications for prenatal androgen exposure.
Schneider HJ; Pickel J; Stalla GK
Psychoneuroendocrinology; 2006 Feb; 31(2):265-9. PubMed ID: 16140461
[TBL] [Abstract][Full Text] [Related]
7. The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism.
Isidori AM; Kaltsas GA; Perry L; Burrin JM; Besser GM; Monson JP
Clin Endocrinol (Oxf); 2003 May; 58(5):601-11. PubMed ID: 12699442
[TBL] [Abstract][Full Text] [Related]
8. Changes in androgens during treatment with four low-dose contraceptives.
Coenen CM; Thomas CM; Borm GF; Hollanders JM; Rolland R
Contraception; 1996 Mar; 53(3):171-6. PubMed ID: 8689882
[TBL] [Abstract][Full Text] [Related]
9. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
Fertil Steril; 2001 Mar; 75(3):554-9. PubMed ID: 11239541
[TBL] [Abstract][Full Text] [Related]
10. Circulating nitric oxide levels increase after anti-androgen treatment in male-to-female transsexuals.
Valenti S; Fazzuoli L; Giusti M
J Endocrinol Invest; 2003 Jun; 26(6):522-6. PubMed ID: 12952365
[TBL] [Abstract][Full Text] [Related]
11. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
Moutos D; Smith S; Zacur H
Contraception; 1995 Aug; 52(2):105-9. PubMed ID: 8536446
[TBL] [Abstract][Full Text] [Related]
12. Novel dehydroepiandrosterone troche supplementation improves the serum androgen profile of women undergoing in vitro fertilization.
Keane KN; Hinchliffe PM; Namdar N; Conceicao JL; Newsholme P; Yovich JL
Drug Des Devel Ther; 2015; 9():5569-78. PubMed ID: 26487801
[TBL] [Abstract][Full Text] [Related]
13. Voice in female-to-male transsexual persons after long-term androgen therapy.
Cosyns M; Van Borsel J; Wierckx K; Dedecker D; Van de Peer F; Daelman T; Laenen S; T'Sjoen G
Laryngoscope; 2014 Jun; 124(6):1409-14. PubMed ID: 24155064
[TBL] [Abstract][Full Text] [Related]
14. Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins.
Wiegratz I; Jung-Hoffmann C; Kuhl H
Contraception; 1995 Jun; 51(6):341-6. PubMed ID: 7554973
[TBL] [Abstract][Full Text] [Related]
15. Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part A. Serum androgen levels in women aged 20-49 years with no complaints of sexual dysfunction.
Guay A; Munarriz R; Jacobson J; Talakoub L; Traish A; Quirk F; Goldstein I; Spark R
Int J Impot Res; 2004 Apr; 16(2):112-20. PubMed ID: 14999217
[TBL] [Abstract][Full Text] [Related]
16. Antimüllerian hormone levels decrease in female-to-male transsexuals using testosterone as cross-sex therapy.
Caanen MR; Soleman RS; Kuijper EA; Kreukels BP; De Roo C; Tilleman K; De Sutter P; van Trotsenburg MA; Broekmans FJ; Lambalk CB
Fertil Steril; 2015 May; 103(5):1340-5. PubMed ID: 25772768
[TBL] [Abstract][Full Text] [Related]
17. Androgens in relationship to cardiovascular risk factors in the menopausal transition.
Mesch VR; Siseles NO; Maidana PN; Boero LE; Sayegh F; Prada M; Royer M; Schreier L; Benencia HJ; Berg GA
Climacteric; 2008; 11(6):509-17. PubMed ID: 18991078
[TBL] [Abstract][Full Text] [Related]
18. Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.
De Pergola G; De Mitrio V; Sciaraffia M; Pannacciulli N; Minenna A; Giorgino F; Petronelli M; Laudadio E; Giorgino R
Metabolism; 1997 Nov; 46(11):1287-93. PubMed ID: 9361687
[TBL] [Abstract][Full Text] [Related]
19. Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women.
Stomati M; Hartmann B; Spinetti A; Mailand D; Rubino S; Albrecht A; Huber J; Petraglia F; Genazzani AR
J Endocrinol Invest; 1996 Sep; 19(8):535-41. PubMed ID: 8905477
[TBL] [Abstract][Full Text] [Related]
20. The grade of hirsutism correlated to serum androgen levels and hormonal indices.
Ruutiainen K; Erkkola R; Kaihola HL; Santti R; Irjala K
Acta Obstet Gynecol Scand; 1985; 64(8):629-33. PubMed ID: 2938400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
